Overview

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process

Status:
Completed
Trial end date:
2003-02-24
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare insulin aspart produced by current process and the NN2000 process.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting